The Role of Attention in Modulating the Placebo Effect
Effects of Attention and Placebo Modulation on Cycling Performance: an Experimental Study on Stationary Bikes
1 other identifier
interventional
128
1 country
1
Brief Summary
This project aims to examine whether these forms of attention to sensory information can modulate the mind-body interaction. This will be demonstrated through a study focused on the placebo effect with attention manipulation. Specifically, the project will focus on the construct of mindful attention to increase the precision of the likelihood and reduce the effects of priors, and on directed attention to modify the position and precision of the likelihood, hypothetically modulating the placebo effect. The study involves recruiting 128 healthy individuals, who will be asked to cycle on an ergometer for approximately 60 minutes, with alternating phases in which attention will be manipulated. After an initial warm-up phase, they will receive a placebo drink, presented as "highly stimulating." An additional group of 32 participants will not receive either the placebo drink or the attentional stimuli, but will undergo the same training cycles. All participants will receive a pre-intervention assessment, and heart rate, emotions, and perceived fatigue will be monitored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2024
CompletedFirst Submitted
Initial submission to the registry
June 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFebruary 14, 2025
January 1, 2025
9 months
June 27, 2024
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fatigue
Numeric Rating Scale 0-10, where 10 indicates maximum fatigue.
30 minutes
Secondary Outcomes (2)
Heart rate
30 minutes
Perceived efficacy of the energy drink
30 minutes
Other Outcomes (6)
Mindfulness
Once, at the baseline (pre-experiment)
Anxiety
Once, at the baseline (pre-experiment)
Stress
Once, at the baseline (pre-experiment)
- +3 more other outcomes
Study Arms (2)
Placebo group
PLACEBO COMPARATORControl Group
ACTIVE COMPARATORInterventions
Participants will be provided with a chest strap for heart rate measurement (the strap will be washed and disinfected after each session), connected to the Polar Beat app downloaded by the researcher. Subsequently, each participant will perform an initial 10-minute baseline warm-up session (a cadence of 70-80 RPM will be requested). From the cycle ergometer display, values for watts (the amount of work done per second), power (the amount of work done over a certain period of time), and speed (expressed in kilometers per hour) will also be extracted. During the test, no visual or verbal feedback will be provided. Participants will be blind to the cycle ergometer screen, so the data will not influence their behavior. Heart rate will be continuously recorded throughout the exercise period and during the participant's recovery. Participants will then be randomized to one of the following manipulations.
Eligibility Criteria
You may qualify if:
- Persons (18+) in good health, verified by presenting a medical certificate (sporting, competitive or non-competitive, or of good health).
- Be available to go to a gym. If not enrolled, the cost of admission is borne by the project.
You may not qualify if:
- known cardiovascular diseases, gastrointestinal diseases, musculoskeletal injuries, upper respiratory tract infections;
- allergy and/or intolerance to caffeine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Università Cattolica del Sacro Cuore
Milan, Milano, 20123, Italy
Study Officials
- STUDY DIRECTOR
Francesca NA Grosso, MD
Catholic University of the Sacred Heart
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 27, 2024
First Posted
February 14, 2025
Study Start
March 7, 2024
Primary Completion
December 12, 2024
Study Completion
May 1, 2025
Last Updated
February 14, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share